These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 12819310)
1. Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. Flack JM; Peters R; Shafi T; Alrefai H; Nasser SA; Crook E J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S92-8. PubMed ID: 12819310 [TBL] [Abstract][Full Text] [Related]
2. [Risk and prevention of diabetic nephropathy]. Ravera M; Re M; Deferrari G G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442 [TBL] [Abstract][Full Text] [Related]
3. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers. Nosadini R; Tonolo G J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive treatment and multifactorial approach for renal protection in diabetes. Fioretto P; Solini A J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S18-21. PubMed ID: 15938027 [TBL] [Abstract][Full Text] [Related]
6. Treatment of hypertension in chronic kidney disease. Toto RD Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269 [TBL] [Abstract][Full Text] [Related]
7. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus]. Ravera M; Deferrari L; Ratto E; Vettoretti S; Parodi D; Deferrari G Ital Heart J Suppl; 2003 Mar; 4(3):210-6. PubMed ID: 12784755 [TBL] [Abstract][Full Text] [Related]
8. Renal protection and antihypertensive drugs: current status. Salvetti A; Mattei P; Sudano I Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294 [TBL] [Abstract][Full Text] [Related]
9. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
10. [Nephrology update. Kidney protection with antihypertensive drugs: I]. Stein G; Fünfstück R; Sperschneider H; Ritz E Med Klin (Munich); 2002 Sep; 97(9):541-6. PubMed ID: 12371082 [TBL] [Abstract][Full Text] [Related]
11. Renal and cardiovascular protection in type 2 diabetes mellitus: angiotensin II receptor blockers. Deferrari G; Ravera M; Deferrari L; Vettoretti S; Ratto E; Parodi D J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S224-9. PubMed ID: 12466318 [TBL] [Abstract][Full Text] [Related]
13. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials. Thomopoulos C; Parati G; Zanchetti A J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660 [TBL] [Abstract][Full Text] [Related]
14. Management of Hypertension in Diabetic Nephropathy: How Low Should We Go? Sternlicht H; Bakris GL Blood Purif; 2016; 41(1-3):139-43. PubMed ID: 26766168 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological strategies for kidney function preservation: are there differences by ethnicity? Lakkis J; Weir MR Adv Ren Replace Ther; 2004 Jan; 11(1):24-40. PubMed ID: 14730536 [TBL] [Abstract][Full Text] [Related]
16. Clinical and therapeutic aspects of diabetic nephropathy. Strippoli GF; Di Paolo S; Cincione R; Di Palma AM; Teutonico A; Grandaliano G; Schena FP; Gesualdo L J Nephrol; 2003; 16(4):487-99. PubMed ID: 14696750 [TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of diabetic nephropathy: the program for irbesartan mortality and morbidity evaluation. Ravera M; Ratto E; Vettoretti S; Parodi D; Deferrari G J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S48-52. PubMed ID: 15938034 [TBL] [Abstract][Full Text] [Related]
18. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects? Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190 [TBL] [Abstract][Full Text] [Related]
19. Improving microvascular outcomes in patients with diabetes through management of hypertension. McGill JB Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966 [TBL] [Abstract][Full Text] [Related]